Form D · Biotechnology
NEUROPRO THERAPEUTICS, INC.
Yachats, OR · CIK 0001681407
Offering snapshot reported Apr 13, 2023 · SEC filing
- Reported sold
- $5.09M Offering amount: $5.09M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 31, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2023 | Initial | $5,092,696 | No comparison | 2 | SEC filing |
| Dec 13, 2016 | Amendment | $215,950 | $50,950vs Aug 3, 2016 | 4 | SEC filing |
| Aug 3, 2016 | Initial | $165,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-478741
Source: Form D, filed Apr 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Luciano Cacioppo | Director |
| Daryl W. Hochman | Director, Executive |
| Louis Serafini | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
18 Basalt Loop
Yachats, OR, 97498
Yachats, OR, 97498